Clinical Trials Directory

Trials / Completed

CompletedNCT02298738

Effect of Vit D on New-onset AF in Hypertension

Relation of Low Vitamin D Levels and New-onset AF Among Hypertensive Patients

Status
Completed
Phase
Study type
Observational
Enrollment
227 (actual)
Sponsor
Ankara University · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

Atrial fibrillation (AF), an important cause of cardiac mortality and morbidity is the most common type of cardiac arrhythmia in clinical practice. Hypertensive individuals are at particular risk of development of atrial fibrillation. Renin-angiotensin-aldosteron system (RAS) which is activated in hypertension may be the underlying mechanism of AF among hypertensive patients. Vitamin D deficiency has been shown to be involved in the pathogenesis of hypertension, cardiovascular disease and obesity. Increased RAS activity is one of the postulated mechanisms by which vitamin D deficiency may trigger the development of hypertension and various cardiovascular diseases. On the basis of these data we hypothesized that hypovitaminosis D might be associated with new-onset AF among patients with hypertension.

Conditions

Timeline

Start date
2012-01-01
Primary completion
2014-11-01
Completion
2014-11-01
First posted
2014-11-24
Last updated
2014-11-24

Source: ClinicalTrials.gov record NCT02298738. Inclusion in this directory is not an endorsement.

Effect of Vit D on New-onset AF in Hypertension (NCT02298738) · Clinical Trials Directory